Patent · US Active

Stable carfilzomib formulations

US10493079B2 · kind B2 · utility

0Cited by

2References

16Claims

0Family size

Assignee

Cipla Limited · IN

Inventors

Harshad Kishore Shete · Solapur, IN
Pankaj Pathak · Davis, US
Sarabjit Singh · Navi Mumbai, IN
Geena Malhotra · Jamkhed, IN

Key dates

Filing date	Sep 11, 2018
Grant date	Dec 3, 2019
Priority date	—
Expiry date	Sep 11, 2038

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K47/18
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are stabilized formulations of carfilzomib. The formulations exhibit increased storage stability relative to other formulations, and are simpler for health care providers to prepare and administer to patients.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.